MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3 β, APPBP2, and mTOR in Alzheimer's disease

CONCLUSION: Our findings suggest that miR-128 suppresses AD pathogenesis, and could be a promising therapeutic target for AD. We also find a possible mechanism underlying the dysregulation of miR-128 in AD, in which Aβ reduces miR-128 expression by inhibiting C/EBPα.PMID:36880288 | DOI:10.1111/cns.14143
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Source Type: research